Casadei B, Argnani L, Guadagnuolo S, Pellegrini C, Stefoni V, Broccoli A, Nanni L, Morigi A, Lolli G, Guarino M, Spinardi L, Pierucci E, Fanti S, Bartoletti M, Dicataldo M, Sabattini E, Bonifazi F, Zinzani PL., Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience., «CANCERS», 2021, 13, pp. 4789 - 4789 [articolo]Open Access
Lalumera E.; Fanti S.; Boniolo G., Reliability of molecular imaging diagnostics, «SYNTHESE», 2021, 198, pp. 5701 - 5717 [articolo]Open Access
Zaorsky NG, Calais J, Fanti S, Tilki D, Dorff T, Spratt DE, Kishan AU., Recensione a: Salvage therapy for prostate cancer after radical prostatectomy., «NATURE REVIEWS. UROLOGY», 2021, 18, pp. 643 - 668 [recensione]
Zanoni L.; Fraccascia N.; Tabacchi E.; Bonfiglioli R.; Stanghellini V.; Barbara G.; Fanti S., SeHCAT test for bile acid malabsorption: may “the old” become “the gold one” in the diagnostic burden of chronic diarrhea?, «CLINICAL AND TRANSLATIONAL IMAGING», 2021, 9, pp. 177 - 180 [articolo]
Caffo O, Frantellizzi V, Monari F, Galli L, Costa RP, Pinto C, Tucci M, Baldari S, Facchini G, Bortolus R, Alongi F, Alongi P, Donner D, Fanti S, Sbrana A, Morabito A, Masini C, Zichi C, Pignata S, Borsatti E, Salgarello M, Spada M, De Giorgi U, Lo Re G, Cortesi E, De Vincentis G., Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without 223Ra., «CANCER BIOTHERAPY & RADIOPHARMACEUTICALS», 2021, 36, pp. 391 - 396 [articolo]
Caffo O, Frantellizzi V, Monari F, Sbrana A, Costa RP, Pinto C, Tucci M, Baldari S, Facchini G, Bortolus R, Alongi F, Alongi P, Palermo A, Fanti S, Biasco E, Murabito A, Filice A, Zichi C, Pignata S, Borsatti E, Salgarello M, Spada M, Cortesi E, Vincentis G., Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients., «FUTURE ONCOLOGY», 2021, 17, pp. 807 - 815 [articolo]
Zamagni E.; Nanni C.; Dozza L.; Carlier T.; Bailly C.; Tacchetti P.; Versari A.; Chauvie S.; Gallamini A.; Gamberi B.; Caillot D.; Patriarca F.; Macro M.; Boccadoro M.; Garderet L.; Barbato S.; Fanti S.; Perrot A.; Gay F.; Sonneveld P.; Karlin L.; Cavo M.; Bodet-Milin C.; Moreau P.; Kraeber-Bodere F., Standardization of 18F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma, «JOURNAL OF CLINICAL ONCOLOGY», 2021, 39, pp. 116 - 125 [articolo]
Abrams-Pompe RS, Fanti S, Schoots IG, Moore CM, Turkbey B, Vickers AJ, Walz J, Steuber T, Eastham JA., The Role of Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Primary Staging of Newly Diagnosed Prostate Cancer: A Systematic Review of the Literature., «EUROPEAN UROLOGY ONCOLOGY», 2021, 4, pp. 370 - 395 [articolo]
Zanoni L, Mei R, Bianchi L, Giunchi F, Maltoni L, Pultrone CV, Nanni C, Bossert I, Matti A, Schiavina R, Fiorentino M, Fonti C, Lodi F, D'Errico A, Brunocilla E, Fanti S., The Role of [18F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [11C]Choline PET/CT and Histopathological Analysis., «CANCERS», 2021, 13, Article number: 1575, pp. 1 - 24 [articolo]Open Access
Zanoni L.; Mei R.; Bianchi L.; Giunchi F.; Maltoni L.; Pultrone C.V.; Nanni C.; Bossert I.; Matti A.; Schiavina R.; Fiorentino M.; Fonti C.; Lodi F.; D'errico A.; Brunocilla E.; Fanti S., The role of [18f]fluciclovine PET/CT in the characterization of high-risk primary prostate cancer: Comparison with [11c]choline PET/CT and histopathological analysis, «CANCERS», 2021, 13, Article number: 1575, pp. 1575 - 1598 [articolo]Open Access
Serenari M.; Bonatti C.; Zanoni L.; Peta G.; Tabacchi E.; Cucchetti A.; Ravaioli M.; Pettinato C.; Bagni A.; Siniscalchi A.; D'Errico A.; Golfieri R.; Fanti S.; Cescon M., The role of hepatobiliary scintigraphy combined with spect/ct in predicting severity of liver failure before major hepatectomy: a single-center pilot study, «UPDATES IN SURGERY», 2021, 73, pp. 197 - 208 [articolo]Open Access
Zanoni L.; Bianchi L.; Nanni C.; Pultrone C.; Giunchi F.; Bossert I.; Matti A.; Schiavina R.; Fiorentino M.; Romagnoli D.; Fonti C.; Lodi F.; D'Errico A.; Brunocilla E.; Porreca A.; Fanti S., [18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2021, 49, pp. 390 - 409 [articolo]
Argalia, Giulia; Malavasi, Silvia; Fortunati, Emilia; Calabrò, Diletta; Campana, Davide; Casadei, Riccardo; Ricci, Claudio; Bevilacqua, Alessandro; Fanti, Stefano; Ambrosini, Valentina, [68Ga]Ga-DOTANOC PET/CT Derived Radiomic Features Can Discriminate Pancreatic Neuroendocrine Tumours from Accessory Spleens: Preliminary Results, «EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING», 2021, 48, pp. 142 - 142 [abstract]
Calabrò, Diletta; Bevilacqua, Alessandro; Malavasi, Silvia; Baiocco, Serena; Ricci, Claudio; Casadei, Riccardo; Campana, Davide; Fanti, Stefano; Ambrosini, Valentina, [68Ga]Ga-DOTANOC PETICT & radiomics: Potential role in discriminating tumor grade in well-differentiated primary pancreatic neuroendocrine tumors, «JOURNAL OF NEUROENDOCRINOLOGY», 2021, 33, pp. 177 - 177 [abstract]
Telo S, Calderoni L, Vichi S, Zagni F, Castellucci P, Fanti S., Alternative and New Radiopharmaceutical Agents for Lung Cancer., «CURRENT RADIOPHARMACEUTICALS», 2020, 13, pp. 185 - 194 [articolo]
